Key result
Targeting vascular inflammation post-CANTOS requires defining optimal timing, patient populations, and therapeutic strategies.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Maffia et al. (2019) studied this question. Targeting vascular inflammation in the post-CANTOS era involves defining the optimal timing, specific patient populations, and appropriate therapeutic strategies.
Synapse has enriched 10 related papers. Consider them for comparative context: